23 January 2013, Lysaker, Norway: Pronova BioPharma ASA's financial calendar
28 February 2013:Â Financial results 4Q and FY 2012
All dates are tentative and subject to changes.
Pronova BioPharma ASA
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Pronova BioPharma ASA via Thomson Reuters ONE